Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin versus melatonin for diabetic polyneuropathy pain
IRCT20191030045277N3Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of pregabalin and melatonin in diabetic polyneuropathy (DPN) (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoint: Neuropathic pain. Started Apr 2024; status: completed.
02
Drugs
pregabalinmelatonin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on IRCT20191030045277N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191030045277N3.